Document Detail


Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
MedLine Citation:
PMID:  18952198     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thyrotropin-releasing hormone (TRH) and its analogs have a number of neurobiological functions and therapeutic uses in disorders of the central nervous system. In this study, the newly synthesized TRH analogs were evaluated for central nervous system activity in pentobarbital-induced sleeping in mice. The most potent TRH analog (L-pGlu-(2-propyl)-L-His-L-ProNH(2) coded as NP-647) was evaluated for its antiepileptic potential in various seizure models in mice in comparison with TRH. Intravenous pretreatment with NP-647 (10 and 20 micromol/kg body wt) significantly delayed the onset and reduced the frequency of convulsions in the pentylenetetrazole model, but not in the maximum electroshock seizure model. Also, it was found to be protective against picrotoxin- and kainic acid-induced seizures. However, NP-647 did not significantly affect theophylline-induced seizures. Further study of the effect of NP-647 on locomotor activity and a functional observational battery revealed that it did not significantly exhibit any undesirable effects as compared with vehicle and TRH. NP-647 did not significantly affect cerebral blood flow, whereas the native peptide TRH markedly increased cerebral blood flow. Furthermore, NP-647 exerted antiepileptic activity without significantly altering plasma thyroid-stimulating hormone levels and mean arterial blood pressure. This suggests that NP-647 is more selective for central nervous system activity and devoid of hormonal and cerebrovascular system effects. In contrast, TRH exhibited cardiac and endocrine effects as marked by significant elevation in mean arterial blood pressure and plasma thyroid-stimulating hormone levels. This study demonstrates that NP-647 has potential antiepileptic activity devoid of undesirable effects and, thus, can be exploited for the prevention and treatment of epilepsy.
Authors:
Satyendra Kumar Rajput; Srinivasan Krishnamoorthy; Chandrasekhar Pawar; Navneet Kaur; Vikramdeep Monga; Chhuttan Lal Meena; Rahul Jain; Shyam S Sharma
Related Documents :
4101368 - Organelles in neuroplasmic ("axonal") flow: neurofilaments.
8322968 - Noncholinergic, nonadrenergic cortical vasodilatation elicited by thalamic centromedian...
16259648 - Cutaneous mechanical stimulation regulates ovarian blood flow via activation of spinal ...
1506448 - Sciatic nerve stimulation does not increase endogenous adenosine production in sensory-...
20202178 - Multi-institutional randomized control study of haemolysis in stored red cell units pre...
17490418 - The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-11-13
Journal Detail:
Title:  Epilepsy & behavior : E&B     Volume:  14     ISSN:  1525-5069     ISO Abbreviation:  Epilepsy Behav     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-12     Completed Date:  2009-04-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100892858     Medline TA:  Epilepsy Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  48-53     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anticonvulsants / pharmacology*,  therapeutic use*,  toxicity
Behavior, Animal / drug effects
Blood Pressure / drug effects
Cardiovascular System / drug effects
Central Nervous System Stimulants / pharmacology
Cerebrovascular Circulation / drug effects
Convulsants / antagonists & inhibitors
Electroshock
Hypnotics and Sedatives / antagonists & inhibitors,  pharmacology
Kainic Acid / antagonists & inhibitors
Male
Mice
Motor Activity / drug effects
Pentylenetetrazole / antagonists & inhibitors
Picrotoxin / antagonists & inhibitors
Rats
Rats, Wistar
Seizures / chemically induced,  prevention & control
Sleep / drug effects
Theophylline / antagonists & inhibitors
Thyrotropin / blood
Thyrotropin-Releasing Hormone / analogs & derivatives*,  pharmacology*,  therapeutic use,  toxicity
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Central Nervous System Stimulants; 0/Convulsants; 0/Hypnotics and Sedatives; 0/pyroglutamyl-(2-propyl)histidyl-prolinamide; 124-87-8/Picrotoxin; 24305-27-9/Thyrotropin-Releasing Hormone; 487-79-6/Kainic Acid; 54-95-5/Pentylenetetrazole; 58-55-9/Theophylline; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The dynamic of lipid oxidation in human myotubes.
Next Document:  Controversies in ulcerative colitis: a survey comparing decision making of experts versus community ...